Company Description

Barinthus Biotherapeutics, formerly Vaccitechm, is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer.